Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective ran

Citation

van Haren PhD, F, Laffey, J, Artigas, A et al. 2022, 'Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective ran', British Journal of Clinical Pharmacology, vol. 88, no. 7, pp. 3272-3287.

Year

2022

ANU Authors

Updated:  01 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers